Stevenson Donald D
Scripps Clinic at Carmel Valley, San Diego, CA 92130, USA.
Curr Allergy Asthma Rep. 2009 Mar;9(2):155-63. doi: 10.1007/s11882-009-0023-4.
NSAIDs-including aspirin (ASA)-that inhibit cyclooxygenase (COX)-1 induce nonallergic hypersensitivity reactions consisting of attacks of rhinitis and asthma. Such reactions occur exclusively in a subset of asthmatic patients who also have underlying nasal polyps and chronic hyperplastic eosinophilic sinusitis. We now refer to their underlying inflammatory disease of the entire respiratory tract as aspirin-exacerbated respiratory disease. This review focuses on descriptions of these patients; methods available to diagnose ASA-exacerbated respiratory disease; the unique ability of all NSAIDs that inhibit COX-1 to cross-react with ASA; lack of cross-reactivity with selective COX-2 inhibitors; an update on pathogenesis; and current thoughts about treatment, including ASA desensitization and daily ingestion of ASA itself.
非甾体抗炎药(NSAIDs),包括阿司匹林(ASA),抑制环氧化酶(COX)-1会引发由鼻炎和哮喘发作组成的非过敏性超敏反应。此类反应仅发生在一部分同时患有鼻息肉和慢性增生性嗜酸性鼻窦炎的哮喘患者中。我们现在将他们整个呼吸道潜在的炎症性疾病称为阿司匹林加重性呼吸道疾病。本综述重点描述这些患者;诊断阿司匹林加重性呼吸道疾病可用的方法;所有抑制COX-1的非甾体抗炎药与阿司匹林交叉反应的独特能力;与选择性COX-2抑制剂无交叉反应;发病机制的最新进展;以及当前关于治疗的观点,包括阿司匹林脱敏和每日服用阿司匹林本身。